Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cresco Labs (CRLBF) Invested Capital (2019 - 2026)

Cresco Labs filings provide 8 years of Invested Capital readings, the most recent being $249.4 million for Q1 2026.

  • On a quarterly basis, Invested Capital fell 33.6% to $249.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $249.4 million, a 33.6% decrease, with the full-year FY2025 number at $273.3 million, down 42.69% from a year prior.
  • Invested Capital hit $249.4 million in Q1 2026 for Cresco Labs, down from $273.3 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $987.7 million in Q4 2022 to a low of $249.4 million in Q1 2026.
  • Median Invested Capital over the past 5 years was $425.9 million (2023), compared with a mean of $500.9 million.
  • Biggest five-year swings in Invested Capital: soared 30.46% in 2022 and later tumbled 56.61% in 2023.
  • Cresco Labs' Invested Capital stood at $987.7 million in 2022, then tumbled by 56.61% to $428.6 million in 2023, then grew by 11.25% to $476.8 million in 2024, then crashed by 42.69% to $273.3 million in 2025, then fell by 8.74% to $249.4 million in 2026.
  • The last three reported values for Invested Capital were $249.4 million (Q1 2026), $273.3 million (Q4 2025), and $340.2 million (Q3 2025) per Business Quant data.